TVGN

Tevogen Bio Holdings (TVGN)

About Tevogen Bio Holdings (TVGN)

Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.

Details

Daily high
$5.51
Daily low
$5.29
Price at open
$5.42
52 Week High
$75.50
52 Week Low
$4.89
Market cap
22.5M
Dividend yield
0.00%
Volume
6,230
Avg. volume
49,112
P/E ratio
-.63

Tevogen Bio Holdings News

Details

Daily high
$5.51
Daily low
$5.29
Price at open
$5.42
52 Week High
$75.50
52 Week Low
$4.89
Market cap
22.5M
Dividend yield
0.00%
Volume
6,230
Avg. volume
49,112
P/E ratio
-.63